Skip to main content
OTCMKTS:ARGSQ

Argos Therapeutics SEC Filings & 10K Form

$0.05
0.00 (0.00 %)
(As of 10/10/2019)
Add
Compare
Today's Range
$0.05
$0.05
50-Day Range
$0.05
$0.05
52-Week Range
$0.02
$0.25
VolumeN/A
Average Volume13,394 shs
Market Capitalization$571,698.00
P/E RatioN/A
Dividend YieldN/A
Beta2.47

SEC Filings

Argos Therapeutics (OTCMKTS:ARGSQ) SEC Filings

DateFilerForm TypeView
05/03/2019
3:10 PM
Argos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2019
10:47 AM
Argos Therapeutics (Subject)
ForArgos B.V. (Filed by)
Form SC 13D/A
12/03/2018
7:01 AM
Argos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/19/2018
2:13 PM
Argos Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/14/2018
1:49 PM
Argos Therapeutics (Filer)
Form NT 10-Q
08/20/2018
3:55 PM
Argos Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/15/2018
6:00 AM
Argos Therapeutics (Filer)
Form NT 10-Q
07/20/2018
3:30 PM
Argos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2018
8:04 AM
Argos Therapeutics (Subject)
The Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
05/15/2018
4:01 PM
Argos Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/15/2018
3:47 PM
Argos Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2018
11:25 AM
Argos Therapeutics (Filer)
Form CT ORDER
04/25/2018
3:59 PM
Abbey Jeffrey D (Reporting)
Argos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/25/2018
3:58 PM
Argos Therapeutics (Issuer)
Katz Richard D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/25/2018
3:58 PM
Argos Therapeutics (Issuer)
Harrelson Lori R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/25/2018
3:57 PM
Argos Therapeutics (Issuer)
Nicolette Charles A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2018
4:29 PM
Argos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/19/2018
7:05 AM
Argos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2018
4:06 PM
Argos Therapeutics (Filer)
Form 424B5
04/02/2018
1:13 PM
Argos Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/02/2018
8:48 AM
Argos Therapeutics (Issuer)
Katz Richard D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2018
7:45 AM
Argos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/30/2018
4:14 PM
Argos Therapeutics (Issuer)
Harrelson Lori R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/30/2018
4:13 PM
Argos Therapeutics (Issuer)
Nicolette Charles A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/30/2018
4:12 PM
Abbey Jeffrey D (Reporting)
Argos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2018
3:31 PM
Argos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/16/2018
7:30 AM
Argos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2018
3:57 PM
Argos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2018
11:15 PM
Argos Therapeutics (Filer)
Form EFFECT
01/18/2018
12:20 PM
Argos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/17/2018
9:44 AM
Argos Therapeutics (Filer)
Form CT ORDER
01/17/2018
9:41 AM
Argos Therapeutics (Filer)
Form CT ORDER
01/12/2018
2:21 PM
Argos Therapeutics (Issuer)
Katz Richard D (Reporting)
Form 4/A
01/12/2018
2:17 PM
Argos Therapeutics (Issuer)
Nicolette Charles A. (Reporting)
Form 4/A
01/12/2018
2:13 PM
Argos Therapeutics (Issuer)
Harrelson Lori R. (Reporting)
Form 4/A
01/12/2018
1:35 PM
Abbey Jeffrey D (Reporting)
Argos Therapeutics (Issuer)
Form 4/A
01/12/2018
1:01 PM
Argos Therapeutics (Issuer)
Harrelson Lori R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/12/2018
12:55 PM
Argos Therapeutics (Issuer)
Nicolette Charles A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/12/2018
12:48 PM
Abbey Jeffrey D (Reporting)
Argos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/12/2018
12:41 PM
Argos Therapeutics (Issuer)
Katz Richard D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2018
7:40 AM
Argos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2018
11:27 AM
Abbey Jeffrey D (Reporting)
Argos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2018
11:12 AM
Argos Therapeutics (Issuer)
Katz Richard D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2018
11:04 AM
Argos Therapeutics (Issuer)
Nicolette Charles A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2018
10:56 AM
Argos Therapeutics (Issuer)
Harrelson Lori R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2018
10:46 AM
Abbey Jeffrey D (Reporting)
Argos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2018
3:31 PM
Argos Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
This page was last updated on 5/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.